[{"address1": "Paasheuvelweg 25", "city": "Amsterdam", "zip": "1105 BP", "country": "Netherlands", "phone": "31 20 240 6000", "website": "https://www.uniqure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.", "fullTimeEmployees": 209, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Klemt", "age": 51, "title": "CFO, Principal Financial Officer & GM of Amsterdam Site", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 679793, "exercisedValue": 0, "unexercisedValue": 282015}, {"maxAge": 1, "name": "Prof. Hugo  Katus", "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Amin  Abujoub Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Eileen  Sawyer", "title": "Vice President of Global Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 15.0, "open": 15.26, "dayLow": 14.72, "dayHigh": 15.34, "regularMarketPreviousClose": 15.0, "regularMarketOpen": 15.26, "regularMarketDayLow": 14.72, "regularMarketDayHigh": 15.34, "payoutRatio": 0.0, "beta": 0.418, "forwardPE": -4.8267975, "volume": 993535, "regularMarketVolume": 983449, "averageVolume": 1410572, "averageVolume10days": 1428810, "averageDailyVolume10Day": 1428810, "bid": 14.72, "ask": 15.12, "bidSize": 13, "askSize": 13, "marketCap": 808347328, "fiftyTwoWeekLow": 3.73, "fiftyTwoWeekHigh": 19.18, "priceToSalesTrailing12Months": 29.807417, "fiftyDayAverage": 12.2469, "twoHundredDayAverage": 10.0246, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 932185536, "profitMargins": 0.0, "floatShares": 44368999, "sharesOutstanding": 54729000, "sharesShort": 5259762, "sharesShortPriorMonth": 3050960, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.09729999, "heldPercentInsiders": 0.084910005, "heldPercentInstitutions": 0.77331, "shortRatio": 3.7, "shortPercentOfFloat": 0.09819999, "impliedSharesOutstanding": 54729000, "bookValue": -0.138, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -239556000, "trailingEps": -4.92, "forwardEps": -3.06, "enterpriseToRevenue": 34.374, "enterpriseToEbitda": -5.502, "52WeekChange": 2.1292372, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 14.77, "targetHighPrice": 68.860634, "targetLowPrice": 12.975019, "targetMeanPrice": 35.78224, "targetMedianPrice": 30.41483, "recommendationMean": 1.46154, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 367520992, "totalCashPerShare": 6.796, "ebitda": -169430000, "totalDebt": 500991008, "quickRatio": 9.323, "currentRatio": 9.744, "totalRevenue": 27119000, "revenuePerShare": 0.557, "returnOnAssets": -0.16394, "returnOnEquity": -2.38461, "grossProfits": -132840000, "freeCashflow": -139787504, "operatingCashflow": -182728000, "revenueGrowth": -0.219, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -7.9626503, "financialCurrency": "USD", "symbol": "QURE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746227190, "regularMarketTime": 1746216000, "exchange": "NMS", "messageBoardId": "finmb_171029664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -1.5333303, "regularMarketPrice": 14.77, "postMarketChangePercent": 0.541638, "postMarketPrice": 14.85, "postMarketChange": 0.0799999, "regularMarketChange": -0.22999954, "regularMarketDayRange": "14.72 - 15.34", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1410572, "fiftyTwoWeekLowChange": 11.040001, "fiftyTwoWeekLowChangePercent": 2.9597857, "fiftyTwoWeekRange": "3.73 - 19.18", "fiftyTwoWeekHighChange": -4.41, "fiftyTwoWeekHighChangePercent": -0.22992699, "fiftyTwoWeekChangePercent": 212.92372, "earningsTimestamp": 1740657900, "earningsTimestampStart": 1746443100, "earningsTimestampEnd": 1746875100, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.92, "epsForward": -3.06, "epsCurrentYear": -3.6105, "priceEpsCurrentYear": -4.090846, "fiftyDayAverageChange": 2.5231009, "fiftyDayAverageChangePercent": 0.20601957, "twoHundredDayAverageChange": 4.7454004, "twoHundredDayAverageChangePercent": 0.47337553, "priceToBook": -107.02899, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "shortName": "uniQure N.V.", "longName": "uniQure N.V.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391610600000, "displayName": "uniQure", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]